MTOR and pancreatic neoplasm: As shown in a study by Coothankandaswamy et al., pharmacological and genetic inhibition of SLC6A14 decreases the proliferation of pancreatic cancer cells both in vitro and in vivo, and blockade of this gene induces tumor cell autophagy and suppresses the mTOR signaling pathway (Figures 2 and 3).61